Sarepta Therapeutics

SRPTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.127 B

$20.14 +0.15%

Close of 21 Sept 2026

Revenue

$2.20B

#1094 by revenue

Earnings

-$713.4M

Loss-making

Shares outstanding

105,627,021

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#102BiohavenBHVN$2.15B
#103Nuvation BioNUVB$2.13B
#104Sarepta TherapeuticsSRPT$2.13B
#105Zenas BioPharmaZBIO$2.12B
#106Trevi TherapeuticsTRVI$2.12B

What if Sarepta Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$286,612.78

Per share 14,231× higher

Bitcoin $1.72T

$16,281.85

Per share 808× higher

Nvidia $5.48T

$51,879.32

Per share 2,576× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Sarepta Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.